Trial Profile
A retrospective study evaluating efficacy of switching treatment from allopurinol to febuxostat in patients with hyperuricemia and evaluate kidney function in patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary) ; Allopurinol
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 30 Dec 2015 New trial record